Impact of Hypertriglyceridemia on Endothelial Dysfunction During Statin ± Ezetimibe Therapy in Patients With Coronary Heart Disease

Despite the use of statin therapy and achieving the target for low-density lipoprotein cholesterol, a substantial number of coronary events are not prevented, and residual risk factors remain unsettled. Recently, ezetimibe has been shown to reduce not only low-density lipoprotein cholesterol but als...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2011-08, Vol.108 (3), p.333-339
Hauptverfasser:	Yunoki, Kei, MD, Nakamura, Kazufumi, MD, PhD, Miyoshi, Toru, MD, PhD, Enko, Kenki, MD, PhD, Kubo, Motoki, MD, Murakami, Masato, MD, PhD, Hata, Yoshiki, MD, PhD, Kohno, Kunihisa, MD, PhD, Morita, Hiroshi, MD, PhD, Kusano, Kengo F., MD, PhD, Ito, Hiroshi, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty, Balloon, Coronary Azetidines - adverse effects Azetidines - therapeutic use Biological and medical sciences Cardiology. Vascular system Cardiovascular Cardiovascular disease Cholesterol, HDL Coronary Artery Bypass Coronary Disease - blood Coronary Disease - drug therapy Coronary heart disease Disorders of blood lipids. Hyperlipoproteinemia Drug Therapy, Combination Endothelium, Vascular - drug effects Ezetimibe Female Heart Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypertriglyceridemia - blood Hypertriglyceridemia - drug therapy Japan Low density lipoprotein Male Medical sciences Metabolic diseases Middle Aged Multivariate Analysis Prescription drugs Prospective Studies Regression Analysis Risk factors Secondary Prevention Statins Triglycerides Triglycerides - blood Vasodilation - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!